SR-9009 (Stenabolic) – Beligas Pharma USA

$89.98

SR-9009, commonly known as Stenabolic, is an investigational compound that has been studied in preclinical research for its interaction with REV-ERB nuclear receptors, which play roles in circadian rhythm regulation, metabolism, and energy balance. Scientific investigations have explored its pharmacological properties and biological activity in controlled laboratory environments. However, SR-9009 is not approved by major regulatory authorities for the treatment, prevention, or diagnosis of any medical condition.